Alnylam Pharmaceuticals (ALNY) Revenue (2009 - 2025)
Alnylam Pharmaceuticals (ALNY) revenue from Jun 30, 2009 to Dec 31, 2025. The TTM Alnylam Pharmaceuticals (ALNY) revenue is $3.71B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Alnylam Pharmaceuticals (ALNY) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +65.19% |
| 3 Years TTM | +52.98% |
| 5 Years TTM | +49.77% |
| 10 Years TTM | +90.63% |
| All Time TTM | +28.57% |
Annual Revenue change of Alnylam Pharmaceuticals (ALNY)
| Year | Revenue | Change |
|---|---|---|
| 2025 | $3.71B | +65.19% |
| 2024 | $2.25B | +22.97% |
| 2023 | $1.83B | +76.23% |
| 2022 | $1.04B | +22.87% |
| 2021 | $844M | +71.31% |
| 2020 | $493M | +124.28% |
| 2019 | $220M | +193.35% |
| 2018 | $75M | -16.68% |
| 2017 | $90M | +90.65% |
| 2016 | $47M | +704.78% |
| 2015 | $5.86M | +128.91% |
| 2014 | $2.56M | +139.25% |
| 2013 | $1.07M | +9.18% |
| 2012 | $980K | -19.01% |
| 2011 | $1.21M | -98.79% |
| 2010 | $100M | -0.49% |
| 2009 | $101M | +4.54% |
| 2008 | $96M | N/A |
Comparison Alnylam Pharmaceuticals (ALNY) five years revenue CAGR with competitors
Alnylam Pharmaceuticals (ALNY) five years revenue CAGR is 49.77%.